Web-based platform for managing cancer pain
A Randomized Controlled, Open Clinical Trial of a Web-based Platform for Multifactorial Intervention in Cancer Pain Management
This study is testing a new app that helps people with cancer pain in rural China track their symptoms and communicate better with their doctors.
Quick facts
| Phase | Phase 3 |
|---|---|
| Study type | Interventional |
| Enrollment | 100 (estimated) |
| Sex | All |
| Sponsor | West China Hospital Academic / other |
| Locations | 1 site (Chengdu, Sichuan) |
| Trial ID | NCT06663956 on ClinicalTrials.gov |
What this trial studies
This clinical trial aims to develop a patient self-reporting applet designed to assist individuals with cancer pain in rural areas of China. The applet will enable participants to report their symptoms and monitor pain levels and medication usage in real-time, facilitating better communication with primary care physicians. By integrating cancer pain management into chronic disease management, the study seeks to enhance healthcare services and improve the quality of life for patients suffering from tumor-related pain. The trial is a Phase 3 interventional study focusing on the effectiveness of this web-based platform.
Who should consider this trial
Good fit: Ideal candidates include patients with confirmed tumors experiencing moderate to severe cancer-related pain requiring morphine-based medication.
Not a fit: Patients with other chronic pain conditions, severe cognitive impairments, or psychiatric illnesses may not benefit from this study.
Why it matters
Potential benefit: If successful, this approach could significantly improve cancer pain management and enhance the quality of life for patients in rural areas.
How similar studies have performed: Other studies have shown promise in using digital platforms for pain management, indicating potential success for this approach.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Patients with tumors that are confirmed by pathological findings. * Presence of tumor-related pain that is moderate or higher and requires intervention with morphine-based pain medication (++). * Have a life expectancy of more than 6 months. * Understand and sign a consent to participate in the study, or if the patient is unable to understand the study, his/her direct caregiver must have a good understanding of the study. Exclusion Criteria: * Presence of other chronic non-cancer pain/have an unresolved pain-related condition. * Moderately severe cognitive impairment/cognitive impairment. * Have schizophrenia or other psychiatric illness. * Neither the patient nor his/her direct caregiver can understand how to use the Cancer Pain Management applet. * Being pregnant.
Where this trial is running
Chengdu, Sichuan
- West China Hospital, Sichuan Universit — Chengdu, Sichuan, China (Recruiting)
Study contacts
- Study coordinator: Xingchen Peng
- Email: pxx2014@163.com
- Phone: 18980606753
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.